At AMP Corporate Event, BioFire Dx, Cepheid Presentations Offer Early Look at MDx Pipelines http://t.co/G64G9tanmR
Biocept Launches Blood-based Lung Cancer Dx to Guide Therapy in Patients Lacking Tissue Biopsy http://t.co/Ip27seTQMC
1
Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases http://t.co/ejJxQVBUuA
1
Gilotrif Survival Data for Del19 and L858R Patients has Implications for Treatment, Research http://t.co/2VAgY8Dza0
Following Republican Election Gain, Detractors of FDA Lab Test Regulation Seize Chance for Support http://t.co/nzXlSzSL5M
Report Finds More Personalized Rx on the Market, but Field Lacks 'Integrator' http://t.co/jvlhCzbsra
Myriad Projects Stronger Revenue Growth in Second Half of FY2015 Driven by CDx, Prolaris http://t.co/6IXYG4B7uc
Drawing Lessons from US Gene Patent Cases, Canadian Hospital Focuses on Enabling NGS Testing http://t.co/s5DCCo4vS8
Study IDs New Loci, Explains 5 Percent of Variation in Cholesterol-Lowering Effects of Statins http://t.co/4MLwBMHDYh
After Health Canada Approval, Spartan Plans to Launch Point-of-Care CYP2C19 Dx via Pharmacy Pilots http://t.co/Y1j0XuL5nu
Genome British Columbia Backs Regional Project to Study Benefits of Pharmacist-guided PGx Testing http://t.co/3pvjLoeHeQ
Arno's Onapristone Program Advancing in Castration-resistant Prostate Cancer, Gynecologic Tumors http://t.co/X00DIBm6tf
People in the News: Luis Gutierrez, Mara Aspinall, Greg Lucier, Valerie Palmieri http://t.co/yjQcva96R8
NanoString Study Shows Prosigna Can Assess Breast Cancer Patients' Risk of Late, Distant Recurrence http://t.co/l2W1UkSfke
